Skip to main content
. 2017 Aug 20;42(3):97–104. doi: 10.1584/jpestics.D17-006

Table 1. The number of RNA-seq paired-end reads acquired for the three A. gossypii clones (NS, MS, and KR).

Sample IDa) Replicate ID No. of RNA-seq paired-end readsb)
Raw Filtered Mapped to reference
NS (N) rep1 36,807,970 29,952,366 23,732,526
rep2 36,718,120 29,131,314 23,566,250
rep3 36,417,536 29,158,596 23,333,644
NS (T) rep1 33,581,112 27,099,350 22,090,390
rep2 34,283,634 27,316,198 22,119,944
rep3 37,757,450 30,506,432 23,567,262
MS (N) rep1 38,883,482 30,185,406 26,480,438
rep2 30,302,292 23,917,022 20,556,194
rep3 32,049,156 25,433,864 21,541,656
MS (T) rep1 38,463,596 33,257,728 28,917,210
rep2 36,832,066 31,746,908 27,596,414
rep3 35,566,136 30,776,962 26,170,864
KR (N) rep1 35,392,952 30,615,400 25,700,126
rep2 37,300,282 29,893,988 21,960,964
rep3 35,562,908 28,725,344 23,160,986
KR (T) rep1 34,926,706 28,174,146 22,975,134
rep2 32,963,336 28,548,450 23,747,834
rep3 32,474,320 28,474,746 22,322,760

a) (N) means without acetamiprid treatment, and (T) means with acetamiprid treatment (0.08 ppm and 0.5 ppm for the susceptible and resistant clone, respectively). b) The number of raw reads, filtered reads, and reads mapped to the reference transcript sequences are shown for three biological replicates (rep1, rep2, and rep3) of each clone treated without or with acetamiprid.